ERASNCT07764276
Enhanced Recovery After Surgery (ERAS) in Patients Undergoing Gynecologic Surgery
A study testing Enhanced Recovery After Surgery (ERAS) and Conventional Perioperative Care in people with ERAS and Gynecologic Surgery, run by National Taiwan University Hospital at 1 site in Taiwan.
Trial summary
Enhanced Recovery After Surgery (ERAS) is a multidisciplinary perioperative care program designed to reduce surgical stress, accelerate postoperative recovery, and improve clinical outcomes. Read more about this study
- Who is it for?
- Ages 18 years and older, women only
- Conditions the study is for
- ERAS, Gynecologic Surgery, Gynecologic Oncological Pelvic/Abdominal Surgery
- What is being tested?
- Enhanced Recovery After Surgery (ERAS) and Conventional Perioperative Care
- Type of treatment
- Pill or oral medicine
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 200 participants
- Where
- 1 siteTaiwan
- Study dates
- 16 May 2024to Dec 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- Women only
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Female scheduled for laparotomic gynecologic surgery (including hysterectomy, myomectomy, adenomyomectomy, oophorectomy or oophrocystectomy, staging surgery, debulking surgery or interval debulking surgery)
- 18 years old or older
- American Society of Anesthesiologists Physical Status classification I to III.
Who cannot join
- Female undergo laparoscopic surgery but are converted to laparotomic surgery
- History of delayed gastric emptying, gastrointestinal motility disorders or chronic pain
- Female undergo emergent surgery.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Taiwan1 site, 1 recruiting
- Recruiting
National Taiwan University Hospital Hsin-Chu Branch
Hsinchu
Chia-Yi Lee, MD, +886-972652431, plzfixthecar@gmail.com
About this study
Official title: The Effect of Enhanced Recovery After Surgery (ERAS) Program in Patients Undergoing Gynecologic Surgery
Enhanced Recovery After Surgery (ERAS) is a multidisciplinary perioperative care program designed to reduce surgical stress, accelerate postoperative recovery, and improve clinical outcomes. This prospective, non-randomized study aims to evaluate the effectiveness of an ERAS program in patients undergoing gynecologic surgery at National Taiwan University Hospital Hsin-Chu Branch. Patients who choose to participate in the ERAS program will receive perioperative care according to the institutional ERAS protocol, while those who choose conventional perioperative care will serve as the comparison group. Perioperative outcomes, postoperative recovery, postoperative complications, pain scores, and other clinical outcomes will be compared between the two groups to evaluate the clinical impact of implementing an ERAS program.
- Being tested
- Enhanced Recovery After Surgery (ERAS), Conventional Perioperative Care
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Enhanced Recovery After Surgery (ERAS)Other
A multidisciplinary perioperative care program designed to reduce surgical stress and enhance postoperative recovery.
Conventional Perioperative CareOther
Standard perioperative care according to routine institutional practice.
| Study group | Role | What they receive |
|---|---|---|
| Enhanced Recovery After Surgery (ERAS) | Experimental | Participants receive perioperative care according to the institutional ERAS protocol, including preoperative education, preoperative carbohydrate intake, optimized anesthesia, multimodal analgesia, early oral feeding, early mobilization, and other evidence-based perioperative care measures. Receives: Other: Enhanced Recovery After Surgery (ERAS) |
| Conventional Perioperative Care | Active comparator | Participants receive conventional perioperative care according to routine institutional practice without implementation of the ERAS protocol. Receives: Other: Conventional Perioperative Care |
What is being measured
The primary outcome is the main question the study is designed to answer.
Time to First Ambulation
Time from return to the hospital ward after surgery to the first ambulation, defined as leaving the bed and standing independently.
Measured: Up to 3 days after surgery
Postoperative Pain Score
Postoperative pain intensity will be assessed using the Numerical Rating Scale (NRS), ranging from 0 to 10, with 0 indicating no pain and 10 indicating the worst possible pain. Higher scores indicate greater pain intensity.
Measured: 4, 8, 16, 24, 48 hours after surgery
Secondary outcomes (6)
Time to First Gas Passage
Measured: Up to 7 days after surgery
Time to First Stool Passage
Measured: Up to 7 days after surgery
Time to removal of Foley catheter
Measured: Up to 7 days after surgery
Postoperative nausea or vomiting
Measured: Up to 7 days after surgery
Overall Postoperative Complication Rate
Measured: Up to 90 days after surgery
Length of Hospital Stay
Measured: Up to 14 days after surgery
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted13 Aug 2026
- Study start16 May 2024
- Primary completionDec 2026 (estimated)
- Study completionDec 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for ERASStudies of the same condition, open and under way.
- More trials run by National Taiwan University HospitalThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 200 participants (estimated)
Sponsor and investigators
- Lead sponsor
- National Taiwan University Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Chia-Yi Lee, MD, Principal investigator, National Taiwan University Hospital Hsin-Chu Branch
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07764276
- Sponsor's protocol ID
- 202402107RINC
- Status last verified
- Aug 2026
- First submitted
- 4 Aug 2026
- Last updated
- 13 Aug 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 13 Aug 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effect of Enhanced Recovery After Surgery (ERAS) Program in Patients Undergoing Gynecologic Surgery
- ClinicalTrials.gov ID
- NCT07764276
- Acronym / sponsor ID
- 202402107RINC
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 200 participants (estimated)
- Lead sponsor
- National Taiwan University HospitalUniversity, hospital or other
- Study start
- 16 May 2024 (actual)
- Primary completion
- Dec 2026 (estimated)
- Study completion
- Dec 2027 (estimated)
- First posted
- 13 Aug 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Enhanced Recovery After Surgery (ERAS) is a multidisciplinary perioperative care program designed to reduce surgical stress, accelerate postoperative recovery, and improve clinical outcomes. This prospective, non-randomized study aims to evaluate the effectiveness of an ERAS program in patients undergoing gynecologic surgery at National Taiwan University Hospital Hsin-Chu Branch. Patients who choose to participate in the ERAS program will receive perioperative care according to the institutional ERAS protocol, while those who choose conventional perioperative care will serve as the comparison group. Perioperative outcomes, postoperative recovery, postoperative complications, pain scores, and other clinical outcomes will be compared between the two groups to evaluate the clinical impact of implementing an ERAS program.
Study design
- Primary purpose
- Treatment
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Enhanced Recovery After Surgery (ERAS) | Experimental | Other: Enhanced Recovery After Surgery (ERAS)Participants receive perioperative care according to the institutional ERAS protocol, including preoperative education, preoperative carbohydrate intake, optimized anesthesia, multimodal analgesia, early oral feeding, early mobilization, and other evidence-based perioperative care measures. |
| Conventional Perioperative Care | Active comparator | Other: Conventional Perioperative CareParticipants receive conventional perioperative care according to routine institutional practice without implementation of the ERAS protocol. |
Who may qualify
- Ages
- 18 years and older
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- Female scheduled for laparotomic gynecologic surgery (including hysterectomy, myomectomy, adenomyomectomy, oophorectomy or oophrocystectomy, staging surgery, debulking surgery or interval debulking surgery)
- 18 years old or older
- American Society of Anesthesiologists Physical Status classification I to III.
Key exclusion criteria (3 listed)
- Female undergo laparoscopic surgery but are converted to laparotomic surgery
- History of delayed gastric emptying, gastrointestinal motility disorders or chronic pain
- Female undergo emergent surgery.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Enhanced Recovery After Surgery (ERAS)A multidisciplinary perioperative care program designed to reduce surgical stress and enhance postoperative recovery. | Other | Enhanced Recovery After Surgery (ERAS) |
| Conventional Perioperative CareStandard perioperative care according to routine institutional practice. | Other | Conventional Perioperative Care |
Primary outcome
Time to First Ambulation
Time frame: Up to 3 days after surgery
Time from return to the hospital ward after surgery to the first ambulation, defined as leaving the bed and standing independently.
Postoperative Pain Score
Time frame: 4, 8, 16, 24, 48 hours after surgery
Postoperative pain intensity will be assessed using the Numerical Rating Scale (NRS), ranging from 0 to 10, with 0 indicating no pain and 10 indicating the worst possible pain. Higher scores indicate greater pain intensity.
6 secondary outcomes
Time to First Gas Passage
Time frame: Up to 7 days after surgery
Time to First Stool Passage
Time frame: Up to 7 days after surgery
Time to removal of Foley catheter
Time frame: Up to 7 days after surgery
Postoperative nausea or vomiting
Time frame: Up to 7 days after surgery
Overall Postoperative Complication Rate
Time frame: Up to 90 days after surgery
Length of Hospital Stay
Time frame: Up to 14 days after surgery
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 13 Aug 2026.
- Individual participant dataSharing planned: No
Related trials for ERAS
Recruiting
Comparison of Post-operative Outcomes Between ERAS Protocol and Non-ERAS Local Regimen in Patients Undergoing Thyroidectomy
Thyroid Diseases, Ambulation Time
Active, not recruitingPhase 1
Comparison of Analgesic Efficacy Between Ultrasound Guided Serratus Anterior Plane Block or Thoracic Paravertebral Block Versus Intravenous Fentanyl for On-pump Coronary Artery Bypass Graft Surgery
Intra and Post Operative Pain Management, Fast Track Program,(Enhanced Recovery After Surgery (ERAS))
RecruitingObservational study
Preoperative Anxiety and One-year Patient-reported Outcomes in Orthopedic Surgery Patients Receiving Enhanced Recovery After Surgery or Conventional Care
Preoperative Anxiety, Orthopedic Surgery
RecruitingPhase 4
The Impact of Perioperative Lidocaine Infusions on Enhanced Recovery After Non-Cardiac Surgery
Pain, Post Operative Analgesia
RecruitingPhase 3
Ferric Derisomaltose and Outcomes in the Recovery of Gynecologic Oncology: ERAS (Enhanced Recovery After Surgery)
Gynecologic Cancer, Anemia
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Chia-Yi Lee, MD principal investigator
National Taiwan University Hospital Hsin-Chu Branch
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Enhanced Recovery After Surgery (ERAS) and Conventional Perioperative Care in people with ERAS and Gynecologic Surgery, run by National Taiwan University Hospital at 1 site in Taiwan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 13 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Chia-Yi Lee, MD (+886-972652431, plzfixthecar@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Time to First Ambulation (time frame: Up to 3 days after surgery). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Aug 2026.